What is the current valuation of the Blood Plasma Derivatives Market as of 2024?

The Blood Plasma Derivatives Market was valued at 43.3 USD Billion in 2024. Read More

What is the projected market size for the Blood Plasma Derivatives Market by 2035?

The market is projected to reach 86.67 USD Billion by 2035. Read More

What is the expected CAGR for the Blood Plasma Derivatives Market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 6.47%. Read More

Which application segments are driving growth in the Blood Plasma Derivatives Market?

The application segments include Immunology, Hematology, Neurology, Oncology, and Infectious Diseases, with valuations ranging from 6.5 to 22.35 USD Billion. Read More

What are the key product types in the Blood Plasma Derivatives Market?

Key product types include Albumin, Immunoglobulin, Coagulation Factors, Clotting Factor Concentrates, and Fibrinogen, with valuations from 5.0 to 30.0 USD Billion. Read More

Who are the leading companies in the Blood Plasma Derivatives Market?

Key players in the market include Grifols, CSL Behring, Takeda Pharmaceutical Company Limited, Octapharma, and Kedrion S.p.A. Read More

What end-use segments are contributing to the Blood Plasma Derivatives Market?

End-use segments include Hospitals, Clinics, Research Laboratories, Blood Banks, and Pharmaceutical Companies, with valuations from 6.0 to 24.67 USD Billion. Read More

How does the market for Immunoglobulin compare to other product types?

Immunoglobulin is projected to have a valuation of 15.0 to 30.0 USD Billion, making it one of the leading product types. Read More

What is the significance of the Oncology segment in the Blood Plasma Derivatives Market?

The Oncology segment is projected to grow from 9.0 to 18.0 USD Billion, indicating its critical role in market expansion. Read More

How are research laboratories positioned in the Blood Plasma Derivatives Market?

Research Laboratories are expected to contribute between 7.0 and 14.0 USD Billion, highlighting their importance in the market. Read More

Blood Plasma Derivatives Market

ID: MRFR/Pharma/0817-HCR

80 Pages

Nidhi Mandole

Last Updated: May 11, 2026

혈장 파생물 시장 조사 보고서 – 2032년까지 예측

요약 목차 세분화 Methodology PDF 다운로드

인증된 연구원

보고서 사용자 정의

5.1 포터의 5가지 힘 분석
5.1.1 공급업체의 협상력
5.1.2 구매자의 협상력
5.1.3 신규 진입자의 위협
5.1.4 대체재의 위협
5.1.5 경쟁의 강도
1. 5.2 가치 사슬 분석
2. 6.1 개요
3. 6.2 제8인자 농축물
4. 6.3 인자 IX 농축액
5. 6.4 알부민
6. 6.5 면역글로불린
7. 6.6 항트롬빈 III 농축액
8. 6.7 신선 동결 혈장(FFP)
9. 7.1 개요
10. 7.2 HIV
11. 7.3 혈우병 A
12. 7.4 B형 혈우병
13. 7.5 B형 간염
14. 7.6 C형 간염
15. 7.7 출혈 장애
16. 7.8 저감마글로불린혈증
17. 7.9 면역결핍 질환
18. 7.10 기타
19. 8.1 개요
20. 8.2 병원 및 진료소
21. 8.3 수혈 센터
22. 8.4 진단 센터
23. 8.5 기타
24. 10.1 개요
25. 10.2 아메리카
  1. 10.2.1 북미
    1. 10.2.1.1 미국
    2. 10.2.1.2 캐나다
  2. 10.2.2 라틴 아메리카
26. 10.3 유럽
  1. 10.3.1 서유럽
    1. 10.3.1.1 독일
    2. 10.3.1.2 프랑스
    3. 10.3.1.3 이탈리아
    4. 10.3.1.4 스페인
    5. 10.3.1.5 영국
    6. 10.3.1.6 기타 서유럽
  2. 10.3.2 동유럽
27. 10.4 아시아 태평양
  1. 10.4.1 일본
  2. 10.4.2 중국
  3. 10.4.3 인도
  4. 10.4.4 호주
  5. 10.4.5 한국
  6. 10.4.6 기타 아시아 태평양
28. 10.5 중동 및 아프리카
  1. 10.5.1 중동
  2. 10.5.2 아프리카
  3. 12.1.1 회사 개요 12.1.2 제품 유형 개요 12.1.3 재무 개요
  4. 12.1.4 주요 개발 사항 12.1.5 SWOT 분석 12.2 Grifols S.A.
  5. 12.2.1 회사 개요 12.2.2 제품 유형 개요 12.2.3 재무 개요 12.2.4 주요 개발 사항 12.2.5 SWOT 분석 12.3 CSL Behring
  6. 12.3.1 회사 개요 12.3.2 제품 유형 개요 12.3.3 재무 개요
  7. 12.3.4 주요 개발 사항 12.3.5 SWOT 분석 12.4 ViroPharma, Inc.
  8. 12.4.1 회사 개요 12.4.2 제품 유형 개요 12.4.3 재무 개요 12.4.4 주요 개발 사항 12.4.5 SWOT 분석 12.5 Talecris Biotherapeutics, Inc.
  9. 12.5.1 회사 개요
  10. 12.5.2 제품 유형 개요
  11. 12.5.3 재무 개요
  12. 12.5.4 주요 개발 사항
  13. 12.5.5 SWOT 분석
29. 12.6 Octapharma
  1. 12.6.1 회사 개요
  2. 12.6.2 제품 유형 개요
  3. 12.6.3 재무 개요
  4. 12.6.4 주요 개발 사항
  5. 12.6.5 SWOT 분석
30. 12.7 Fusion Healthcare
  1. 12.7.1 개요
  2. 12.7.2 제품 유형 개요
  3. 12.7.3 재무 개요
  4. 12.7.4 주요 개발 사항
  5. 12.7.5 SWOT 분석
31. 12.8 SK플라즈마(주)
  1. 12.8.1 개요
  2. 12.8.2 제품 유형 개요
  3. 12.8.3 재무 개요
  4. 12.8.4 주요 개발 사항
  5. 12.8.5 SWOT 분석
32. 12.9 Biotest AG
  1. 12.9.1 개요
  2. 12.9.2 제품 유형 개요
  3. 12.9.3 재무 개요
  4. 12.9.4 주요 개발 사항
  5. 12.9.5 SWOT 분석
33. 12.10 녹십자(주)
  1. 12.10.1 개요
  2. 12.10.2 제품 유형 개요
  3. 12.10.3 재무 개요
  4. 12.10.4 주요 개발 사항
  5. 12.10.5 SWOT 분석
34. 12.11 Shire Plc
  1. 12.11.1 개요
  2. 12.11.2 제품 유형 개요
  3. 12.11.3 재무 개요
  4. 12.11.4 주요 개발 사항
  5. 12.11.5 SWOT 분석
35. 12.13 기타
36. 13.1 참고문헌
37. 13.2 관련 보고서

인증된 연구원

보고서 사용자 정의

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”